Arcturus Therapeutics Holdings
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10628 Science Center Dr, San Diego, Cali...Phone Number
(858) 900-2660Website
www.arcturusrx.comRevenue
$42.4 MillionStock Symbol
ARCTIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
3
1
1
2
2
About Arcturus Therapeutics Holdings
Arcturus Therapeutics, as presented on its official site and in public company information, is a biotechnology company that focuses on the development of innovative messenger RNA-based medicines and vaccines. It leverages proprietary RNA technologies and lipid-mediated delivery systems to advance a diverse pipeline of therapeutic and vaccine candidates, including programs aimed at rare diseases and infectious illnesses. The organization is known for its work in mRNA science and for collaborating globally to bring novel RNA therapies and preventive solutions forward, with a multicultural team driving research, clinical development, and business initiatives from its headquarters in the United States.Explore more
Arcturus Therapeutics Holdings Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Arcturus Therapeutics Holdings your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Arcturus Therapeutics Holdings had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Arcturus Therapeutics Holdings
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Arcturus Therapeutics Holdings has new funding data
Product Launch: Get notified when Arcturus Therapeutics Holdings launches new products
Check out if Arcturus Therapeutics Holdings is spiking on competitors!
Website visits: Recent activity has been detected on your website
Arcturus Therapeutics Holdings, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Arcturus Therapeutics Holdings has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Arcturus Therapeutics Holdings recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Arcturus Therapeutics Holdings
Compare insights from companies similar to Arcturus Therapeutics Holdings, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Arcturus Therapeutics Hol...
$42.4M
51-200
Public
$407.9M
2013
Pad ChivukulaChief Operating Officer and CSO
$97.4M
201-500
Public
$237.2M
1997
John DesjarlaisExecutive Vice President & Research & Scientific Chief & Officer
Company Profile Activity
Activity Insights
Arcturus Therapeutics Holdings is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Arcturus Therapeutics Holdings is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Arcturus Therapeutics Holdings.
Arcturus Therapeutics Holdings financials insights
Gather financial insights about Arcturus Therapeutics Holdings, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Debt
$5.9M
2020
Multiple Rounds
$393M
2023
Other Financing Round
$9M
Arcturus Therapeutics Holdings Tech Stack
A closer look at the technologies used by Arcturus Therapeutics Holdings
See more technologies
Most Recent Scoops
Open Position
Person-Based
Partnership, Medical Research, Pharmaceuticals
Open Position
Person-Based
Pharmaceuticals
New Hire
Executive Move
Executive Moves, New Hire
Arcturus Therapeutics Holdings News & Media
Arcturus Therapeutics Q2 Earnings Call Highlights
Arcturus Therapeutics (NASDAQ:ARCT) reported progress across its rare-disease pipeline during the second quarter of 2026, completed enrollment and dosing in its Phase II ornithine transcarbamylase deficiency study, and regained global rights to its KOSTAIVE COVID-19 vaccine and self-amplifying mRNAArcturus Therapeutics Holdings Inc. (ARCT) Shareholder/Analyst Call Prepared Remarks Transcript
Arcturus Therapeutics Holdings Inc. (ARCT) Shareholder/Analyst Call June 5, 2026 12:00 PM EDTCompany ParticipantsJoseph Payne - Founder, President, CEO...Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call Transcript
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDTCompany ParticipantsNeda Safarzadeh - Vice President and Head of...Cathie Wood Adds 48K Shares to This Under-the-Radar Growth Play
Wood trimmed stakes in Nvidia, Meta, and Tesla; instead, she added this speculative biotech play.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Arcturus Therapeutics Holdings
Sign Up For FreeTo access detailed company insights
Arcturus Therapeutics, as presented on its official site and in public company information, is a biotechnology company that focuses on the development of innovative messenger RNA-based medicines and vaccines. It leverages proprietary RNA technologies and lipid-mediated delivery systems to advance a diverse pipeline of therapeutic and vaccine candid... Read More
